Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

MRK

MRK Stock Analysis – Key Insights for Investors

Large-cap Health Care company Merck & has logged a -1.2% change today on a trading volume of 1,474,136. The average volume for the stock is 14,117,607.

Merck & Co., Inc. operates as a healthcare company worldwide. Based in Rahway, United States the company has 73,000 full time employees and a market cap of $207,490,580,480. Merck & currently offers its equity investors a dividend that yields 3.8% per year.

Over the last 12 months MRK shares have declined by -28.4%, which represents a difference of -44.3% when compared to the S&P 500. The stock's 52 week high is $120.3 per share and its 52 week low is $73.31. Based on Merck &'s average net margin growth of 1.1% over the last 6 years, its core business remains strong and the stock price may recover in the long term.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2024 64,168,000 17,117,000 27 2600.0
2023 60,115,000 365,000 1 -95.83
2022 59,283,000 14,519,000 24 -11.11
2021 48,704,000 13,049,000 27 58.82
2020 41,518,000 7,067,000 17 -32.0
2019 39,121,000 9,843,000 25
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS